https://www.selleckchem.com/pr....oducts/filgotinib.ht
d evaluations are required to analyze the effects of concurrent valve ablation and bladder neck incision on renal outcome. Intravesical BCG (Bacillus Calmette-Guérin) therapy is indicated as an effective treatment for patients with non-muscle-invasive bladder cancer, despite associate with the side effects. In this study, the incidence of BCG therapy adverse effects was compared among three groups of patients who received celecoxib, phenazopyridine, and oxybutynin with placebo. The randomized controlled clinical trial was conducted o
Like
Comment
Share
